Literature DB >> 24263694

Clinical application of 3D arterial spin-labeled brain perfusion imaging for Alzheimer disease: comparison with brain perfusion SPECT.

H Takahashi1, K Ishii2, C Hosokawa2, T Hyodo2, N Kashiwagi2, M Matsuki2, R Ashikaga2, T Murakami2.   

Abstract

BACKGROUND AND
PURPOSE: Alzheimer disease is the most common neurodegenerative disorder with dementia, and a practical and economic biomarker for diagnosis of Alzheimer disease is needed. Three-dimensional arterial spin-labeling, with its high signal-to-noise ratio, enables measurement of cerebral blood flow precisely without any extrinsic tracers. We evaluated the performance of 3D arterial spin-labeling compared with SPECT, and demonstrated the 3D arterial spin-labeled imaging characteristics in the diagnosis of Alzheimer disease.
MATERIALS AND METHODS: This study included 68 patients with clinically suspected Alzheimer disease who underwent both 3D arterial spin-labeling and SPECT imaging. Two readers independently assessed both images. Kendall W coefficients of concordance (K) were computed, and receiver operating characteristic analyses were performed for each reader. The differences between the images in regional perfusion distribution were evaluated by means of statistical parametric mapping, and the incidence of hypoperfusion of the cerebral watershed area, referred to as "borderzone sign" in the 3D arterial spin-labeled images, was determined.
RESULTS: Readers showed K = 0.82/0.73 for SPECT/3D arterial spin-labeled imaging, and the respective areas under the receiver operating characteristic curve were 0.82/0.69 for reader 1 and 0.80/0.69 for reader 2. Statistical parametric mapping showed that the perisylvian and medial parieto-occipital perfusion in the arterial spin-labeled images was significantly higher than that in the SPECT images. Borderzone sign was observed on 3D arterial spin-labeling in 70% of patients misdiagnosed with Alzheimer disease.
CONCLUSIONS: The diagnostic performance of 3D arterial spin-labeling and SPECT for Alzheimer disease was almost equivalent. Three-dimensional arterial spin-labeled imaging was more influenced by hemodynamic factors than was SPECT imaging.
© 2014 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24263694     DOI: 10.3174/ajnr.A3780

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  18 in total

Review 1.  Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.

Authors:  Christina E Wierenga; Chelsea C Hays; Zvinka Z Zlatar
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Fluid-attenuated inversion recovery vascular hyperintensities in predicting cerebral hyperperfusion after intracranial arterial stenting.

Authors:  Chih-Cheng Wan; David Yen-Ting Chen; Ying-Chi Tseng; Feng-Xian Yan; Kun-Yu Lee; Chen-Hua Chiang; Chi-Jen Chen
Journal:  Neuroradiology       Date:  2017-07-08       Impact factor: 2.804

Review 3.  The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.

Authors:  Chelsea C Hays; Zvinka Z Zlatar; Christina E Wierenga
Journal:  Cell Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.046

4.  Multimodal assessment of regional gray matter integrity in early relapsing-remitting multiple sclerosis patients with normal cognition: a voxel-based structural and perfusion approach.

Authors:  Hossein Shooli; Reza Nemati; Negar Chabi; Mykol Larvie; Narges Jokar; Habibollah Dadgar; Ali Gholamrezanezhad; Majid Assadi
Journal:  Br J Radiol       Date:  2021-09-07       Impact factor: 3.039

5.  Three-dimensional pulsed continuous arterial spin labeling and intravoxel incoherent motion imaging of nasopharyngeal carcinoma: correlations with Ki-67 proliferation status.

Authors:  Wenxiu Wu; Guihua Jiang; Zhifeng Xu; Ruoning Wang; Aizhen Pan; Mingyong Gao; Tian Yu; Linwen Huang; Qiang Quan; Jin Li
Journal:  Quant Imaging Med Surg       Date:  2021-04

6.  Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?

Authors:  Sander C J Verfaillie; Sofie M Adriaanse; Maja A A Binnewijzend; Marije R Benedictus; Rik Ossenkoppele; Mike P Wattjes; Yolande A L Pijnenburg; Wiesje M van der Flier; Adriaan A Lammertsma; Joost P A Kuijer; Ronald Boellaard; Philip Scheltens; Bart N M van Berckel; Frederik Barkhof
Journal:  Eur Radiol       Date:  2015-04-22       Impact factor: 5.315

7.  Amide proton transfer magnetic resonance imaging of Alzheimer's disease at 3.0 Tesla: a preliminary study.

Authors:  Rui Wang; Sa-Ying Li; Min Chen; Jin-Yuan Zhou; Dan-Tao Peng; Chen Zhang; Yong-Ming Dai
Journal:  Chin Med J (Engl)       Date:  2015-03-05       Impact factor: 2.628

8.  Multimodal MRI for early diabetic mild cognitive impairment: study protocol of a prospective diagnostic trial.

Authors:  Ying Yu; Qian Sun; Lin-Feng Yan; Yu-Chuan Hu; Hai-Yan Nan; Yang Yang; Zhi-Cheng Liu; Wen Wang; Guang-Bin Cui
Journal:  BMC Med Imaging       Date:  2016-08-24       Impact factor: 1.930

Review 9.  Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression.

Authors:  Fatimah Zara Javaid; Jonathan Brenton; Li Guo; Maria F Cordeiro
Journal:  Front Neurol       Date:  2016-04-19       Impact factor: 4.003

10.  Alteration of Venous Drainage Route in Idiopathic Normal Pressure Hydrocephalus and Normal Aging.

Authors:  Takeshi Satow; Toshihiko Aso; Sei Nishida; Taro Komuro; Tsukasa Ueno; Naoya Oishi; Yukako Nakagami; Masashi Odagiri; Takayuki Kikuchi; Kazumichi Yoshida; Keita Ueda; Takeharu Kunieda; Toshiya Murai; Susumu Miyamoto; Hidenao Fukuyama
Journal:  Front Aging Neurosci       Date:  2017-11-23       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.